• $138.7M
    Market Cap
  • 165.10%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
64,000
-99.75%
26.0M
N/A
0
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
64,000
-99.75%
26.0M
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-37.8M
+29.20%
-29.3M
-43.64%
-51.9M
-92.04%
-652.2M
+25.90%
Depreciation and Amortization Expense
704,000
+6.67%
660,000
N/A
N/A
N/A
N/A
N/A
Total Operating Expenses
58.1M
+19.91%
48.5M
N/A
N/A
N/A
N/A
N/A
Operating Profit
-58.1M
+158.66%
-22.5M
-63.83%
-62.1M
-92.29%
-805.6M
+27.58%
Interest Income
2.3M
-49.07%
4.5M
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
-23,000
-84.03%
-144,000
+26.32%
Interest Income and Expense and Net
2.3M
-49.07%
4.5M
+19,460.87%
-23,000
-84.03%
-144,000
+26.32%
Total Nonoperating Income and Expense
2.8M
-60.39%
7.0M
+346.01%
1.6M
-75.46%
6.4M
-66.11%
Income before Taxes
-55.3M
+258.86%
-15.4M
-74.11%
-59.5M
-92.53%
-797.1M
-39.01%
Income Taxes
197,000
-11.66%
223,000
+85.83%
120,000
-94.11%
2.0M
+20.04%
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-55.5M
+255.00%
-15.6M
-73.74%
-59.5M
-92.53%
-797.1M
-39.01%
Net Income from Continuing Operations Applicable to Common
-55.3M
+258.86%
-15.4M
-74.11%
-59.5M
-92.53%
-797.1M
-39.01%
Basic EPS and Net Income
-1.00
+257.14%
-0.28
-74.07%
-1.08
-92.55%
-14.50
-42.00%
Diluted EPS and Net Income
-1.00
+257.14%
-0.28
-74.07%
-1.08
-92.55%
-14.50
-42.00%
Basic Weighted Average Shares
55.7M
+0.81%
55.2M
+0.27%
55.1M
+0.04%
55.0M
+5.49%
Diluted Weighted Average Shares
55.7M
+0.81%
55.2M
+0.27%
55.1M
+0.04%
55.0M
+5.49%
Balance Sheet
Cash and Cash Equivalents
38.3M
-50.99%
78.2M
-26.20%
106.0M
-80.74%
550.3M
-67.76%
Short-Term Investments
6.0M
-61.25%
15.5M
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
44.3M
-52.68%
93.7M
-11.60%
106.0M
-80.74%
550.3M
-67.76%
Total Current Assets
50.9M
-47.47%
97.0M
-19.85%
121.0M
-88.85%
1.1B
-38.15%
Accumulated Depreciation
3.3M
+25.23%
2.6M
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
3.8M
-5.93%
4.0M
-5.29%
4.3M
-87.67%
34.7M
-41.59%
Total Long-Term Assets
646,000
+1,857.58%
33,000
-99.33%
4.9M
-96.12%
127.0M
+25.09%
Total Assets
56.1M
-44.64%
101.3M
-19.55%
125.9M
-89.61%
1.2B
-34.69%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
13.6M
+60.87%
8.5M
-65.13%
24.3M
-77.70%
108.8M
-5.10%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
114,000
-82.62%
656,000
+12.14%
585,000
-90.63%
6.2M
+20.92%
Total Liabilities
14.1M
+54.58%
9.1M
-63.31%
24.8M
-78.40%
115.1M
-3.98%
Retained Earnings
-400.8M
+16.06%
-345.4M
-35.97%
-539.3M
-83.01%
-3.2B
+33.52%
Total Stockholders Equity
42.0M
-54.45%
92.2M
-8.79%
101.0M
-90.79%
1.1B
-36.81%
Total Shares Outstanding
56.4M
+1.97%
55.3M
-3.75%
57.5M
+0.10%
57.4M
-0.06%
Cash Flow
Cash from Operating Activities
-51.2M
+116.86%
-23.6M
-50.74%
-47.9M
-92.95%
-679.7M
+24.73%
Capital Expenditures
434,000
-42.13%
750,000
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
9.8M
+384.50%
-3.5M
-104.59%
75.2M
+113.15%
-571.3M
+1,579.09%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
1.1M
+381.50%
227,000
+192.28%
-246,000
-60.64%
-625,000
-100.05%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
-90,740.62%
+105,113.35%
-86.24%
N/A
N/A
N/A
N/A
N/A
Return on Assets
-70.51%
+412.51%
-13.76%
+54.67%
-8.90%
-82.88%
-51.97%
N/A
Return on Equity
-82.72%
+411.31%
-16.18%
+62.84%
-9.93%
-82.35%
-56.28%
N/A
Revenue Growth
-99.75%
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
3.74
-67.35%
11.46
+129.83%
4.99
-50.00%
9.97
N/A
Cash Ratio
2.82
-69.53%
9.25
+111.61%
4.37
-13.61%
5.06
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow